Detalles de la búsqueda
1.
Relationships among the Dosage of Erythropoiesis-Stimulating Agents, Erythropoietin Resistance Index, and Mortality in Maintenance Hemodialysis Patients.
Blood Purif
; 51(2): 171-181, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34175850
2.
Yishen capsule promotes podocyte autophagy through regulating SIRT1/NF-κB signaling pathway to improve diabetic nephropathy.
Ren Fail
; 43(1): 128-140, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33427556
3.
Risk Factor Analysis for AKI Including Laboratory Indicators: a Nationwide Multicenter Study of Hospitalized Patients.
Kidney Blood Press Res
; 42(5): 761-773, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29136619
4.
Gut-Skin Axis: Unravelling the Link Between Gut Microbiome and Chronic Kidney Disease-Related Skin Lesions.
Endocr Metab Immune Disord Drug Targets
; 24(1): 39-49, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171004
5.
CD163 as a Potential Biomarker-associated Immune Inflammation in Diabetes Mellitus: A Systematic Review and Bioinformatics Analysis.
Endocr Metab Immune Disord Drug Targets
; 24(2): 208-219, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37455460
6.
Identification of Novel Hub Genes Associated with Inflammation and Autophagy in Astragaloside Membranaceus ameliorates Lupus Nephritis by Bioinformatics Analysis and Molecular Dynamics Simulation.
Comb Chem High Throughput Screen
; 2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38299290
7.
Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathway.
PLoS One
; 19(5): e0304365, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38820434
8.
Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule).
BMC Complement Altern Med
; 13: 76, 2013 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-23560927
9.
Effect of SGLT2 Inhibitors and Metformin on Inflammatory and Prognostic Biomarkers in Type 2 Diabetes Patients.
Endocr Metab Immune Disord Drug Targets
; 23(4): 530-547, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36043731
10.
Astragaloside IV Inhibited Podocyte Pyroptosis in Diabetic Kidney Disease by Regulating SIRT6/HIF-1α Axis.
DNA Cell Biol
; 42(10): 594-607, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37751175
11.
Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy.
PLoS One
; 17(9): e0273498, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094934
12.
Yishen Capsule Alleviated Symptoms of Diabetic Nephropathy via NOD-like Receptor Signaling Pathway.
Diabetes Metab Syndr Obes
; 15: 2183-2195, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923253
13.
Potential Molecular Mechanism of Yishen Capsule in the Treatment of Diabetic Nephropathy Based on Network Pharmacology and Molecular Docking.
Diabetes Metab Syndr Obes
; 15: 943-962, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35378831
14.
[Effects of astragaloside IV on delaying kidney aging and its mechanisms].
Zhongguo Ying Yong Sheng Li Xue Za Zhi
; 38(5): 448-452, 2022 Sep.
Artículo
en Zh
| MEDLINE | ID: mdl-37088750
15.
Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology.
Evid Based Complement Alternat Med
; 2022: 6987677, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36561604
16.
Effects of Probiotic Preparations on Inflammatory Cytokines in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
Curr Pharm Biotechnol
; 22(10): 1338-1349, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33213338
17.
Bioinformatics analysis of genes related to iron death in diabetic nephropathy through network and pathway levels based approaches.
PLoS One
; 16(11): e0259436, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34735495
18.
Effectiveness of Chinese herbal medicine combined with Western medicine on deferring dialysis initiation for nondialysis chronic kidney disease stage 5 patients: a multicenter prospective nonrandomized controlled study.
Ann Transl Med
; 9(6): 490, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33850887
19.
Efficacy and safety of Shenyankangfu Tablet, a Chinese patent medicine, for primary glomerulonephritis: A multicenter randomized controlled trial.
J Integr Med
; 19(2): 111-119, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33589406
20.
Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury.
Stem Cells Int
; 2020: 8875554, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33381189